Arthur J. Gallagher & Co. AJG SPX
Company Overview
Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance and reinsurance brokerage, consulting, and third-party property/casualty claims settlement and administration services to entities and individuals worldwide. The company operates in Brokerage and Risk Management segments. Its Brokerage segment offers retail and wholesale insurance and reinsurance brokerage services; assists retail brokers and other non-affiliated brokers in the placement of specialized and hard-to-place insurance; and acts as a brokerage wholesaler, managing general agent, and managing general underwriter for distributing specialized insurance coverages to underwriting enterprises. This segment performs activities, including marketing, underwriting, issuing policies, collecting premiums, appointing and supervising other agents, paying claims, and negotiating reinsurance; and offers services in the areas of insurance and reinsurance placement, risk of loss management, and management of employer sponsored benefit programs. The Risk Management segment provides contract claim settlement and administration services; and claims management, loss control consulting, and insurance property appraisal services. The company offers its services through a network of correspondent brokers and consultants. It serves commercial, industrial, public, religious, and nonprofit entities, as well as underwriting enterprises. The company was founded in 1927 and is headquartered in Rolling Meadows, Illinois.
Why Investors Should Care
Net profit has compounded at 10.3% per year over the last five years.
Revenue has grown at a 17.7% CAGR over the past five years.
Operating margin of 28.4% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $13.94B (+20.7% YoY); net profit $1.49B.
- Trailing 12 Months Year-on-year growth — revenue +34.6%, earnings +16.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 17.7%, profit CAGR 10.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 17.70% |
| 1 Year: | 34.60% |
Compounded Profit Growth
| 5 Years: | 10.27% |
| 1 Year: | 16.20% |
Stock Price Performance
| 1 Year: | -18.62% |
| 6 Months: | -3.45% |
| 3 Months: | +14.46% |
| 1 Month: | +14.91% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)67.44 · Neutral
P/E of 41.01 is above the sector median of 13.30 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 17.7% over 5 years.
- Profit CAGR of 10.3% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AJG Arthur J. Gallagher & Co. SPX | 253.83 | 41.01 | $65.22B | 1.28% | 6.58% | 7.01% | 17.70% | 10.27% |
| 2 | JPM JPMorgan Chase & Co. SPX | 342.89 | 16.42 | $918.78B | 1.87% | - | 16.47% | 5.35% | 7.56% |
| 3 | BRK-B Berkshire Hathaway Inc. SPX | 491.09 | 14.61 | $686.70B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPX | 356.02 | 31.01 | $590.89B | 0.83% | 37.15% | 60.35% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPX | 538.02 | 31.10 | $471.86B | 0.71% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPX | 60.62 | 15.04 | $430.20B | 2.00% | - | 10.64% | 6.00% | 3.49% |
| 7 | MS Morgan Stanley SPX | 227.67 | 20.62 | $359.10B | 1.87% | - | 16.39% | 3.76% | 9.66% |
| 8 | GS The Goldman Sachs Group, Inc. SPX | 1,140.00 | 20.83 | $336.31B | 1.69% | - | 14.55% | - | 2.21% |
| 9 | WFC Wells Fargo & Company SPX | 85.29 | 13.18 | $261.00B | 2.11% | - | 12.03% | 4.02% | 15.98% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 1.65B | 1.49B | 1.59B | - | 1.84B | 1.66B | 1.78B | - | 1.99B | 1.66B | 1.83B | 1.72B | 1.87B | 1.58B | 1.85B | 1.70B | 2.17B | 1.93B | 2.14B | 2.44B | 2.04B | 2.04B | 2.71B | 2.44B | 2.49B | 3.26B | 2.78B | - | 3.73B | 3.22B | 3.37B | 3.63B | 4.76B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.94B | 1.85B | 1.97B | 2.25B | 2.56B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.79B | 1.37B | 1.39B | 1.38B | 2.20B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 745.00M | 750.10M | 857.10M | 1.03B | 982.00M |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.05B | 624.40M | 536.60M | 348.10M | 1.22B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.29B | 860.80M | 784.00M | 702.70M | 1.54B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 158.00M | 158.60M | 160.80M | 161.20M | 158.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 873.00M | 471.40M | 346.90M | 180.00M | 1.04B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 164.00M | 105.20M | 73.30M | 25.70M | 220.00M |
| Net Income | 139.30M | 133.30M | 62.30M | 46.50M | 150.00M | 122.80M | 95.10M | 228.80M | 70.00M | 111.00M | 71.50M | 273.70M | 114.90M | 127.60M | 117.30M | 334.10M | 110.10M | 126.10M | 98.50M | 346.30M | 153.70M | 176.60M | 142.20M | 382.10M | 190.20M | 225.10M | 438.70M | 284.20M | 255.80M | 486.50M | 234.50M | 280.70M | 608.40M | 283.40M | - | 704.00M | 365.80M | 272.70M | 151.10M | 822.00M |
| Diluted EPS | 0.81 | 0.75 | - | 0.26 | 0.84 | 0.69 | - | 1.27 | 0.39 | 0.61 | - | 1.48 | 0.62 | 0.68 | - | 1.77 | 0.58 | 0.66 | 0.51 | 1.79 | 0.79 | 0.90 | 0.72 | 1.92 | 0.92 | 1.06 | 2.05 | 1.33 | 1.19 | 2.24 | 1.07 | 1.28 | 2.74 | 1.27 | - | 2.72 | 1.40 | 1.04 | 0.58 | 3.16 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.65B | 1.73B | 1.86B | 2.13B | 2.52B | 3.18B | 4.63B | 5.39B | 5.68B | 6.25B | 6.93B | 7.20B | 7.00B | - | 8.55B | 10.07B | 11.55B | 13.94B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.95B | 5.83B | 6.68B | 8.01B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.60B | 4.25B | 4.88B | 5.94B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.93B | 2.39B | 2.60B | 3.38B |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.67B | 1.86B | 2.28B | 2.56B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.18B | 2.18B | 3.10B | 3.63B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 256.90M | 297.00M | 381.00M | 639.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.33B | 1.19B | 1.88B | 1.87B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 211.00M | 219.00M | 404.00M | 368.00M |
| Net Income | 77.30M | 128.60M | 174.10M | 144.10M | 195.00M | 268.60M | 303.40M | 356.80M | 396.80M | 481.30M | 633.50M | 668.80M | 818.80M | - | 1.11B | 970.00M | 1.46B | 1.49B |
| Diluted EPS | 0.82 | 1.28 | 1.66 | 1.28 | 1.59 | 2.06 | 1.97 | 2.06 | 2.22 | 2.64 | 3.40 | 3.52 | 4.20 | - | 5.19 | 4.42 | 6.50 | 5.74 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 3.25B | 3.60B | 4.48B | 5.35B | 6.86B | 10.01B | 10.91B | 13.53B | 14.91B | 16.33B | 19.63B | 22.33B | - | 38.36B | 51.62B | 64.25B | 70.67B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.29B | 32.12B | 44.11B | 34.36B |
| Cash & Equivalents | 255.90M | 194.40M | 205.90M | 249.80M | 291.20M | 302.10M | 298.10M | 314.40M | 480.40M | 545.50M | 681.20M | 607.20M | 604.80M | 664.60M | - | 738.40M | 971.50M | 14.99B | 1.40B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.91B | 3.79B | 3.90B | 5.17B |
| Total Liabilities | - | - | 2.36B | 2.49B | 3.24B | 3.69B | 4.78B | 6.70B | 7.22B | 7.83B | 10.61B | 11.76B | 14.42B | 16.10B | 24.78B | 29.17B | 40.80B | 44.08B | - |
| Current Liabilities | - | - | 1.47B | 1.58B | 2.07B | 2.36B | 3.28B | 3.64B | 4.19B | 4.61B | 6.73B | 7.69B | 8.92B | 10.13B | - | 21.34B | 31.06B | 29.26B | 32.52B |
| Long Term Debt | - | - | 550.00M | 550.00M | 675.00M | 725.00M | 825.00M | 2.12B | 2.07B | 2.14B | 2.69B | 3.09B | 3.82B | 4.27B | - | 5.56B | 7.01B | 12.73B | 12.10B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.42B | 8.32B | 13.48B | 13.48B |
| Total Equity | 715.50M | 738.50M | 892.90M | 1.11B | 1.24B | 1.66B | 2.09B | 3.23B | 3.64B | 3.60B | 4.24B | 4.50B | 5.16B | 6.19B | - | 9.14B | 10.78B | 20.15B | 23.32B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 211.90M | 216.70M | 250.00M | 257.00M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 160.60M | 211.50M | 229.50M | 284.00M | 343.00M | 349.90M | - | - | 649.60M | 854.20M | 765.10M | 1.19B | 1.81B | - | 1.39B | 2.03B | 2.58B | 1.93B |
| Investing Cash Flow | -262.10M | -94.60M | -92.60M | -311.20M | -382.20M | -851.70M | - | - | -485.30M | -511.00M | -910.30M | -1.45B | -471.40M | - | -1.00B | -3.29B | -1.59B | -15.88B |
| Financing Cash Flow | 40.00M | -105.40M | -96.20M | 65.60M | 45.90M | 502.60M | - | - | -11.60M | -47.80M | 162.00M | 638.40M | -505.10M | - | 212.60M | 2.87B | 13.05B | 1.71B |
| Capital Expenditure | -32.00M | -23.50M | -25.10M | -45.90M | -51.00M | -93.60M | -81.50M | -99.00M | -217.80M | - | - | - | - | - | -182.70M | -194.00M | -142.00M | -145.00M |
| Free Cash Flow | 128.60M | 188.00M | 204.40M | 238.10M | 292.00M | 256.30M | - | - | 431.80M | - | - | - | - | - | 1.21B | 1.84B | 2.44B | 1.78B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 597.80M | 1.61B | 14.05B | -12.23B |
| Share Buybacks | 1.30M | 1.00M | 800.00K | 1.20M | 1.50M | - | - | - | 101.00M | 17.70M | 11.30M | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.1% | 42.2% | 42.2% | 42.6% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.5% | 18.5% | 19.7% | 18.3% |
| Net Margin % | 4.7% | 7.4% | 9.3% | 6.8% | 7.7% | 8.4% | 6.6% | 6.6% | 7.0% | 7.7% | 9.1% | 9.3% | 11.7% | - | 13.0% | 9.6% | 12.7% | 10.7% |
| ROE % | 10.5% | 14.4% | 15.7% | 11.6% | 11.8% | 12.9% | 9.4% | 9.8% | 11.0% | 11.4% | 14.1% | 13.0% | 13.2% | - | 12.2% | 9.0% | 7.3% | 6.4% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.8% | 9.1% | 6.5% | 6.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | JPMORGAN CHASE & CO | 7.62% | 19.57M | $4.85B |
| 2 | Blackrock Inc. | 7.52% | 19.31M | $4.79B |
| 3 | Vanguard Capital Management LLC | 6.50% | 16.70M | $4.14B |
| 4 | FMR, LLC | 5.69% | 14.62M | $3.63B |
| 5 | Capital World Investors | 5.38% | 13.82M | $3.43B |
| 6 | Vanguard Portfolio Management LLC | 4.83% | 12.42M | $3.08B |
| 7 | State Street Corporation | 4.27% | 10.97M | $2.72B |
| 8 | Dodge & Cox Inc. | 2.86% | 7.35M | $1.82B |
| 9 | Geode Capital Management, LLC | 2.43% | 6.24M | $1.55B |
| 10 | Morgan Stanley | 1.58% | 4.06M | $1.01B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AJG
Arthur J. Gallagher (AJG) Acquires Med James To Expand Specialty Insurance Reach
Arthur J. Gallagher (NYSE:AJG) has acquired Med James, Inc., a Kansas based managing general agency and wholesale insurance broker. The transaction expands Gallagher's specialty insurance platform and will be integrated into its Risk Placem…
Arthur J. Gallagher (AJG) Stock May Trade At A Discount To Fair Value Yet A Premium On Earnings
Arthur J. Gallagher stock has delivered a 101.5% return over the past 5 years, yet its current checks send mixed valuation signals, with an intrinsic value estimate from the Excess Returns model pointing to a discount while market multiples…
Arthur J. Gallagher (AJG) Rebounds Sharply, Is The Upside Already Priced In?
Arthur J. Gallagher (AJG) has caught investor attention after a recent stretch of positive share performance, with the stock up 3.2% over the past week and 19.5% over the past month. See our latest analysis for Arthur J. Gallagher. Set agai…
US Insurance to See Property Pricing Headwinds in Q2, RBC Says
Marsh (MRSH), American International Group (AIG), and other US insurance intermediaries and carriers
BRO Lags Industry, Trades at a Discount: What Investors Should Do Now?
Brown & Brown's commission growth, acquisitions and diversified operations support long-term expansion, though higher expenses, debt and international risks remain.
AJG Strengthens Specialty Insurance Through Med James Acquisition
Arthur J. Gallagher expands its specialty insurance platform with the Med James acquisition, strengthening wholesale brokerage and MGA capabilities to support long-term growth.
AJG — Frequently Asked Questions
What is the current share price of Arthur J. Gallagher & Co. (AJG)?
As of 2026-07-14 21:23 PDT, Arthur J. Gallagher & Co. (AJG) trades at $253.83 on NYSE. Its 52-week range is $191.36 to $311.89.
What is the market capitalisation of AJG?
Arthur J. Gallagher & Co. (AJG) has a market capitalisation of $65.22B on NYSE.
What is the P/E ratio of AJG?
AJG trades at a trailing price-to-earnings (P/E) ratio of 41.01. The industry average P/E is 13.30. Its price-to-book (P/B) ratio is 2.36.
Does AJG pay a dividend?
Arthur J. Gallagher & Co. (AJG) currently offers a dividend yield of 1.28%.
What is the return on equity (ROE) of AJG?
AJG has a return on equity (ROE) of 7.01%. Its return on capital employed (ROCE) is 6.58%.
Is AJG a good stock to buy?
This page provides a data-driven analysis of Arthur J. Gallagher & Co. (AJG), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.